The New Jersey Department of Health said it has confirmed seven cases of meningococcal disease at Princeton, with all but one of the cases involving students.
The meningitis has been identified as "Type B," which is not covered by the standard vaccine commonly administered to students in the United States.
The Centers for Disease Control and Prevention (CDC) is making an experimental vaccine available to Princeton, and officials at the northeastern US university said they are in the process of deciding whether to administer it to students.
Located in the state of New Jersey, Princeton is considered among America's premier universities and has an enrollment of some 8,000 students.
Meningitis can progress rapidly within hours of the onset of symptoms, and if untreated can lead to shock or death.
Health official say complications can include hearing loss, brain damage or kidney disease.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
